Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.
- NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_assertion description "[Major signalling pathways that could play significant role in lung cancer therapy include (1) Growth promoting pathways (Epidermal Growth Factor Receptor/Ras/ PhosphatidylInositol 3-Kinase) (2) Growth inhibitory pathways (p53/Rb/P14ARF, STK11) (3) Apoptotic pathways (Bcl-2/Bax/Fas/FasL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.
- NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_assertion evidence source_evidence_literature NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.
- NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_assertion SIO_000772 23276293 NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.
- NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_assertion wasDerivedFrom befree-2016 NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.
- NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_assertion wasGeneratedBy ECO_0000203 NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.
- befree-2016 importedOn "2016-02-19" NP1039506.RAHTybHmOd2IGgDFpohh2ZqYfR2U9C-J949B4buro7NTg130_provenance.